P. J. Visser

Dickkopf-1 Overexpression in vitro Nominates Candidate Blood Biomarkers Relating to Alzheimer’s Disease Pathology

R. Dobson, K. Blennow, J. Molinuevo, 2020, Journal of Alzheimer's disease : JAD.

Outcome measures for Alzheimer’s disease: A global inter-societal Delphi consensus

Christopher J. Weber, J. Morris, C. Lyketsos, 2023, Alzheimer's & dementia : the journal of the Alzheimer's Association.

Large-scale cerebrospinal fluid proteomic analysis in Alzheimer's disease patients reveals five molecular subtypes with distinct genetic risk profiles.

F. Barkhof, P. Visser, Y. Pijnenburg, 2023, medRxiv.

Paired plasma lipidomics and proteomics analysis in the conversion from mild cognitive impairment to Alzheimer's disease.

K. Sleegers, P. Proitsi, B. Tijms, 2024, Computers in biology and medicine.

A competing risk joint model for dealing with different types of missing data in an intervention trial in prodromal Alzheimer’s disease

D. Rizopoulos, S. Swinkels, Floor M. van Oudenhoven, 2021, Alzheimer's Research & Therapy.

Discovery and validation of plasma proteomic biomarkers relating to brain amyloid burden by SOMAscan assay

K. Blennow, J. Molinuevo, P. Scheltens, 2019, Alzheimer's & Dementia.